A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

By Livnat Jerby-Arnon, Parin Shah, Michael S. Cuoco, Christopher Rodman, Mei-ju Su, Johannes C. Melms, Rachel Leeson, Abhay Kanodia, Shaolin Mei, Jia-Ren Lin and 42 more. Cell, 2018

692 citations recorded by the source corpus.

SUMMARY Immune checkpoint inhibitors (ICIs) produce durable responses in some melanoma patients, but many patients derive no clinical benefit, and the molecular underpinnings of such resistance remain elusive. Here, we leveraged single-cell RNA sequencing (scRNA-seq) from 33 melanoma tumors and computational analyses to interrogate malignant cell states that promote immune evasion. We identified a resistance program expressed by malignant cells that is associated with T cell exclusion and immune evasion. The program is expressed prior to immunotherapy, characterizes cold niches in situ, and predicts clinical responses to anti-PD-1 therapy in an independent cohort of 112 melanoma patients. CDK4/6-inhibition represses this program in individual malignant cells, induces senescence, and reduces melanoma tumor outgrowth in mouse models in vivo when given in combination with immunotherapy. Our study provides a high-resolution landscape of ICI-resistant cell states, identifies clinically predictive signatures, and suggests new therapeutic strategies to overcome immunotherapy resistance.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/d7716e35d2eb1423457353e2113fbfd6b9b27f28

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. Aviv Regev
  2. Lisa M. Coussens
  3. D. DeNardo
  4. K. Polyak
  5. K. Flaherty
  6. X. Zhuang
  7. J. Massagué
  8. Nir Hacohen

In Oncology

  1. Lisa M. Coussens
  2. J. Massagué
  3. D. DeNardo
  4. K. Polyak
  5. Carlo C. Maley
  6. K. Flaherty
  7. Nikolaus Schultz
  8. Garry P. Nolan

Citations in the corpus